Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Europa
Fresenius Medical Care AG & Co. KGaA
Nieuws
Fresenius Medical Care AG & Co. KGaA
FME
XET
: FME
| ISIN: DE0005785802
26/04/2024
37,42 EUR
(-0,98%)
(-0,98%)
26/04/2024
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Dividend
Technische analyse
TA
Toon enkel gratis nieuws
22 maart 2024 ·
Fresenius Medical Care publishes 2023 joint Annual Report and Sustainability Report: Shaping the Future of Kidney Care
· Persbericht
19 maart 2024 ·
Fresenius Medical Care launches "Augmented Reality" for training on Kidney Replacement Therapy device
· Persbericht
13 maart 2024 ·
Fresenius Medical Care appoints Jörg Häring as new Management Board member responsible for Legal, Compliance and Human Resources
· Persbericht
5 maart 2024 ·
Fresenius Medical Care Achieves Next Milestone in Portfolio Optimization Program, Announcing Sale of Dialysis Clinics in Brazil, Colombia, Chile, Ecuador
· Persbericht
20 februari 2024 ·
Fresenius Medical Care delivers on commitments in a year of fundamental transformation
· Persbericht
8 februari 2024 ·
Fresenius Medical Care Brings Industry-Leading Dialysis Therapy to Kidney Disease Patients in the U.S., demonstrating Global Leadership in Medical Device and Membrane Engineering Technologies
· Persbericht
5 februari 2024 ·
Fresenius Medical Care AG nominates Six Employee Representatives to the Supervisory Board
· Persbericht
8 januari 2024 ·
Fresenius Medical Care Executes on Its Strategic Portfolio Optimization Program and Announces Key Transactions
· Persbericht
1 november 2023 ·
Fresenius Medical Care continues to execute on turnaround plan and raises 2023 earnings outlook due to strong operational performance in first nine months and solid business outlook for the fourth quarter
· Persbericht
31 oktober 2023 ·
Fresenius Medical Care appoints Craig Cordola as new Management Board member for Care Delivery
· Persbericht
31 oktober 2023 ·
Fresenius Medical Care Demonstrates Commitment to Innovating Dialysis and Kidney Disease Care with Presentations at the American Society of Nephrology (ASN) Kidney Week 2023
· Persbericht
26 oktober 2023 ·
Fresenius Medical Care Achieves Key AI Milestone With First-Phase Completion of Largest Global Dialysis Clinical Dataset
· Persbericht
18 oktober 2023 ·
Capital Square Delivers 149.59% Total Return* to Investors in Medical Building DST
· Persbericht
12 oktober 2023 ·
Mee m/d markt :'Aftellen naar inflatiedata VS'
· Bolero.be
Er was gisteren heel wat animo op de beursvloer, maar de winst op indexniveau bleef in Europa beperkt tot 0,15% en liep op tot 0,4% in de VS. Groene cijfers, dus, daags na wat de grootste dagwinst was sinds begin 2023. Gisteren...
11 oktober 2023 ·
Capital Square Delivers 147.63% Total Return* to Investors in Medical Building DST
· Persbericht
23 augustus 2023 ·
Fresenius Medical Care Announces FDA Clearance of Versi®HD with GuideMe Software
· Persbericht
9 augustus 2023 ·
Fresenius Medical Care Partners with Sarah Bush Lincoln to Provide Life-Sustaining Care to Rural Patients
· Persbericht
2 augustus 2023 ·
Fresenius Medical Care successfully executes strategic plan and narrows guidance range due to strong operational performance in the first half of 2023
· Persbericht
14 juli 2023 ·
Fresenius Medical Care simplifies corporate structure by converting into a German stock corporation
· Persbericht
10 juli 2023 ·
Fresenius Medical Care appoints Martin Fischer as Chief Financial Officer
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe